Insider trading

Period: 120 months Stock: NKTR + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

338 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

338 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

338 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

338 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
338 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
338 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

338 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
16 May 2019
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$108.57K 3,461 at 31.37
3.5%
16 May 2019
Hora Maninder SVP Pharma Dev & Mfg Ops
Sold, plan not stated
$76.83K 2,449 at 31.37
2.5%
16 May 2019
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$60.48K 1,928 at 31.37
1.2%
21 Feb 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.37M 33,333 at 41.01
9.7%
20 Feb 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.44M 33,334 at 43.20
9.7%
19 Feb 2019
ROBIN HOWARD W President & CEO
Sold, plan not stated 2×
$1.79M 42,215 at 42.33
12.0%
19 Feb 2019
Nicholson John SVP & Chief Operating Officer
Sold, plan not stated
$162.01K 3,822 at 42.39
2.2%
19 Feb 2019
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$152.26K 3,592 at 42.39
2.7%
19 Feb 2019
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$140.31K 3,310 at 42.39
3.2%
19 Feb 2019
Hora Maninder SVP Pharma Dev & Mfg Ops
Sold, plan not stated
$101.14K 2,386 at 42.39
2.4%
19 Feb 2019
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$76.64K 1,808 at 42.39
1.1%
4 Feb 2019
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$679.58K 16,119 at 42.16
8.7%
28 Jan 2019
Nicholson John SVP & Chief Operating Officer
Sold, plan not stated
$2.70M 63,000 at 42.82
26.5%
16 Nov 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$586.22K 15,326 at 38.25
5.8%
16 Nov 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$249.20K 6,515 at 38.25
5.8%
16 Nov 2018
Nicholson John SVP & Chief Operating Officer
Sold, plan not stated
$228.81K 5,982 at 38.25
3.3%
16 Nov 2018
Hora Maninder SVP Pharma Dev & Mfg Ops
Sold, plan not stated
$179.55K 4,694 at 38.25
5.5%
16 Nov 2018
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$173.04K 4,524 at 38.25
5.4%
16 Nov 2018
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$153.61K 4,016 at 38.25
2.5%
20 Sep 2018
Lingnau Lutz Director
Sold, plan not stated
$512.82K 9,000 at 56.98
32.8%
20 Sep 2018
Sold, plan not stated
$383.13K 6,750 at 56.76
30.0%
19 Sep 2018
CHESS ROBERT Director
Sold, plan not stated
$255.65K 4,500 at 56.81
1.6%
4 Sep 2018
GREER R SCOTT Director
Sold, plan not stated
$673.90K 10,000 at 67.39
7.1%
21 Aug 2018
WINGER DENNIS L Director
Sold, plan not stated
$904.50K 15,000 at 60.30
26.0%
17 Aug 2018
WINGER DENNIS L Director
Sold, plan not stated
$894.30K 15,000 at 59.62
26.0%
14 Aug 2018
WINGER DENNIS L Director
Sold, plan not stated
$1.03M 17,125 at 60.15
28.6%
13 Aug 2018
WINGER DENNIS L Director
Sold, plan not stated
$1.05M 17,125 at 61.04
22.2%
27 Jun 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.05M 43,333 at 47.39
16.2%
26 Jun 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.14M 43,333 at 49.36
16.2%
25 Jun 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$2.25M 43,334 at 51.82
16.2%
6 Jun 2018
GREER R SCOTT Director
Sold, plan not stated
$516.00K 8,600 at 60.00
6.2%
6 Jun 2018
WHITFIELD ROY A Director
Bought 2×
$201.86K 3,400 at 59.37
2.0%
First buy on file
5 Jun 2018
CHESS ROBERT Director
Sold, plan not stated
$551.60K 10,000 at 55.16
3.5%
5 Jun 2018
WHITFIELD ROY A Director
Bought
$88.35K 1,600 at 55.22
0.9%
First buy on file
4 Jun 2018
GREER R SCOTT Director
Sold, plan not stated
$86.79K 1,400 at 61.99
1.1%
16 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$1.07M 12,791 at 83.39
5.4%
16 May 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$412.03K 4,941 at 83.39
5.0%
16 May 2018
Nicholson John SVP & Chief Operating Officer
Sold, plan not stated
$410.03K 4,917 at 83.39
2.9%
16 May 2018
Hora Maninder SVP Pharma Dev & Mfg Ops
Sold, plan not stated
$338.56K 4,060 at 83.39
5.1%
16 May 2018
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$298.20K 3,576 at 83.39
5.2%
16 May 2018
Doberstein Stephen K SVP & Chief Scientific Officer
Sold, plan not stated
$286.44K 3,435 at 83.39
5.1%
3 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$3.59M 43,333 at 82.86
15.4%
3 May 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$2.49M 30,000 at 82.86
23.1%
3 May 2018
CHESS ROBERT Director
Sold, plan not stated 2×
$2.07M 25,000 at 82.80
8.4%
2 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$3.71M 43,333 at 85.63
15.4%
2 May 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$2.57M 30,000 at 85.63
23.1%
1 May 2018
ROBIN HOWARD W President & CEO
Sold, plan not stated
$3.62M 43,334 at 83.65
15.4%
1 May 2018
Labrucherie Gil M SVP & Chief Financial Officer
Sold, plan not stated
$2.51M 30,000 at 83.65
23.1%
16 Apr 2018
Thomsen Jillian B. SVP & Chief Accounting Officer
Sold, plan not stated
$1.41M 13,881 at 101.46
16.8%
10 Apr 2018
Hora Maninder SVP Pharma Dev & Mfg Ops
Sold, plan not stated
$53.05K 502 at 105.67
0.6%
Showing 201–250 of 338. ← Newer Page 5 of 7 Older →